Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Migraine Disorders: HELP
Mitchell F. Brin
Based on 11 articles published since 2009
(Why 11 articles?)
||||
Expertise Level
The expertise of Mitchell F. Brin ranks in the
  • Top 1.3%
  • ... of 21,857 published authors worldwide on Migraine Disorders
  • ... from 2009 through 2019
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Aliases Brin, Mitchell F   ·   Brin, M F
Work Locations
Details
Most likely:    Allergan Inc.      
2017
  • Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California, Irvine, CA, USA. · Pubmed 27910097
  • Neurology Center, Encinitas, CA, USA. · Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · Department of Neurology, Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California at Irvine, Irvine, CA, USA. · Department of Head and Neck Surgery, University of California at Los Angeles, Los Angeles, CA, USA. · Pubmed 28387038
2014
  • Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA Harvard Medical School, Boston, MA, USA. · Allergan Inc., Irvine, CA, USA. · Allergan Inc., Irvine, CA, USA University of California, Irvine, CA, USA · Pubmed 24694964
2009
  • Allergan, LLC, 2525 Dupont Drive, Irvine, CA 92612-1599, USA. · Pubmed 19470342
2014
Probable:    University of California Irvine   Contact    
2017
  • Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California, Irvine, CA, USA. · Pubmed 27910097
  • Neurology Center, Encinitas, CA, USA. · Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · Department of Neurology, Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California at Irvine, Irvine, CA, USA. · Department of Head and Neck Surgery, University of California at Los Angeles, Los Angeles, CA, USA. · Pubmed 28387038
2014
  • Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA Harvard Medical School, Boston, MA, USA. · Allergan Inc., Irvine, CA, USA. · Allergan Inc., Irvine, CA, USA University of California, Irvine, CA, USA · Pubmed 24694964
Probable:    Miscellaneous cities in California      
2016
  • Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Harvard Medical School, USA. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Clinical Research Center, Soroka University Medical Center, Israel Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel. · Allergan plc, Ireland University of California, USA. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Harvard Medical School, USA · Pubmed 26984967
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Mitchell F. Brin about Migraine Disorders:

  • Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies. 2017
  • Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes. 2017
  • Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle? 2016
  • Development of onabotulinumtoxinA for chronic migraine. 2014
  • Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains. 2014
  • Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine. 2014
  • OnabotulinumtoxinA for treatment of chronic migraine: a response. 2011
  • OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. 2010
  • OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. 2010
  • OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. 2010
Show List of Full Article Records
Google Searches

Learn more about Mitchell F. Brin using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Allergan Inc.
University of California Irvine
Miscellaneous cities in California
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Allergan Inc.
2017
  • Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California, Irvine, CA, USA. · Pubmed 27910097
  • Neurology Center, Encinitas, CA, USA. · Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · Department of Neurology, Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California at Irvine, Irvine, CA, USA. · Department of Head and Neck Surgery, University of California at Los Angeles, Los Angeles, CA, USA. · Pubmed 28387038
2014
  • Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA Harvard Medical School, Boston, MA, USA. · Allergan Inc., Irvine, CA, USA. · Allergan Inc., Irvine, CA, USA University of California, Irvine, CA, USA · Pubmed 24694964
2009
  • Allergan, LLC, 2525 Dupont Drive, Irvine, CA 92612-1599, USA. · Pubmed 19470342
2014
University of California Irvine
2017
  • Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California, Irvine, CA, USA. · Pubmed 27910097
  • Neurology Center, Encinitas, CA, USA. · Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · Department of Neurology, Stanford University, Stanford, CA, USA. · Allergan plc, Irvine, CA, USA. · Department of Neurology, University of California at Irvine, Irvine, CA, USA. · Department of Head and Neck Surgery, University of California at Los Angeles, Los Angeles, CA, USA. · Pubmed 28387038
2014
  • Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA Harvard Medical School, Boston, MA, USA. · Allergan Inc., Irvine, CA, USA. · Allergan Inc., Irvine, CA, USA University of California, Irvine, CA, USA · Pubmed 24694964
Miscellaneous cities in California
2016
  • Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Harvard Medical School, USA. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Clinical Research Center, Soroka University Medical Center, Israel Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel. · Allergan plc, Ireland University of California, USA. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Harvard Medical School, USA · Pubmed 26984967
3 Other Locations Show
Yearly article counts 00210300131
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.